Dialogue with African Biotech Leaders: Biotechnology for Gender Equality
Release Date: 05/14/2024
AMA Series on Investment Funding for Biotech - Legal Essentials for Biotech Startups
Africa Biotech Conversations
This session focuses on the essential legal and funding strategies for early-stage biotech startups, emphasizing the importance of intellectual property (IP) management, legal structures, and the role of due diligence in attracting investors. The panel discusses common pitfalls, the significance of contracts, and the challenges of commercializing university IP. They also explore the timing of freedom to operate studies and the evolving landscape of biotech investment. For this session, the featured guests were: Chyreene Truluck – Partner at Spoor & Fisher, specializing in intellectual...
info_outline
OneBio Innovation Center: A Pioneering Space for Biotech Startups in Africa
Africa Biotech Conversations
In this episode of the Africa Biotech Conversations Podcast, host Adrienne Leussa welcomes Erin Rencken, General Manager of the newly launched OneBio Innovation Center (OBIC) in Cape Town, South Africa. The special episode features a live recording from the launch event and a detailed discussion about OBIC's mission, offerings, and community-building efforts. Erin outlines the center's vision to provide biotech startups with essential lab space, equipment, and a collaborative environment. The conversation also highlights the support received from the Technology Innovation Agency...
info_outline
Proteinea: Pioneering the Development of the First Fully African-Originated Drug
Africa Biotech Conversations
In this episode of the "Africa Biotech Conversations" podcast, host Adrienne Leussa interviews Abdulaziz El Gamal, the co-founder and Chief Product Officer of Proteinea. Proteinea, based in Cairo and Boston, is a tech-bio company focused on leveraging AI to develop next-generation biologics, particularly antibodies with enhanced efficacy, safety, and convenience. Key Points from the Episode: Company Background: Proteinea was founded in early 2020, right before the global pandemic, which influenced its strategic direction and provided a real-time showcase of biotech's potential in health...
info_outline
AMA Series on Investment Funding for Biotech - The Art of Valuation for Early-Stage Biotech Startups
Africa Biotech Conversations
The LinkedIn Live session, part of the AMA series on "The Art of Valuation," focused on valuation strategies for biotech startups at early and post-Series A stages. Moderated by Dr. Adrienne Leussa, the discussion featured finance experts Olufemi Elegbe, CFA and Sewu-Steve Tawia. Key highlights included the importance of financial literacy for biotech entrepreneurs, methods for accurately valuing biotech startups, and strategies for enhancing valuation after Series A. The session also emphasized the need for tailored communication when presenting valuations to investors and included practical...
info_outline
AMA Series on Investment Funding for Biotech - Understanding the Investment Ecosystem (Pre-seed Focus)
Africa Biotech Conversations
In this insightful episode of the "Ask Me Anything" series on funding and investment, the focus was on early-stage biotech entrepreneurs in Africa. Adrienne was joined by Gian-Marco Melfi, a partner at OneBio Venture Studios, who shared his expertise on the unique challenges and strategies relevant to securing investment in the biotech sector. The discussion covered the intricacies of biotech investments, including the importance of understanding the investment landscape, targeting the right type of investors (such as angel investors, family offices, and venture capitalists), and...
info_outline
AMA Series on Investment Funding for Biotech - Building Investor Relations
Africa Biotech Conversations
In this comprehensive session of the ongoing dialogue with African biotech leaders, the focus was on building and maintaining investor relationships. Joining Adrienne were seasoned experts, including Dr. Vuyisile Phehane and Gian-Marco Melfi, who are regular contributors, along with first-time guests Natasha Drapeau and Frank Schwarz from Cohesion Bureau. The discussion covered best practices for engaging with investors, emphasising the importance of communication, the strategic presentation of business plans, and the need for biotech startups to clearly articulate their value...
info_outline
AMA Series on Investment Funding for Biotech - Common Pitfalls in Securing Funding
Africa Biotech Conversations
In this episode of the "Ask Me Anything" series under the Dialogue with African Biotech Leaders, experts Gian-Marco Melfi and Vuyisile Phehane discuss the nuances of funding for biotech startups. Focusing on the early stages of startup financing, the conversation explores the challenges startups face in securing funding, the importance of aligning with the right investors, and effective strategies for engaging potential backers. Gian-Marco Melfi, from One Bio Venture Studio, emphasises the significance of building strong, capable teams, while Vuyisile Phehane from the Technology Innovation...
info_outline
AMA Series on Investment Funding for Biotech - Where's the Money and How Do I Get It?
Africa Biotech Conversations
In this first episode of the "Ask Me Anything" (AMA) series focused on Investment Funding for biotech, held live on LinkedIn, we delved into the intricate world of funding for biotech startups. The session features profound insights from Dr. Vuyisile Phehane, the Executive: Bio-Economy at South Africa's National Technology Innovation Agency (TIA), and Mr. Gian-Marco Melfi, an investment principal at One BioVenture Studio. Together, they explore the diverse sources of funding available to biotech startups in Africa and provide practical advice on navigating the complex investment landscape....
info_outline
Dialogue with African Biotech Leaders: Your 2024 Biotech Growth Plan from Africa and Beyond
Africa Biotech Conversations
Welcome to another retrospective episode of the Dialogue with African Biotech Leaders. In this special session, titled "Going Global: Your 2024 Biotech Growth Plan from Africa and Beyond," we explore cutting-edge strategies for biotech leaders aiming for significant growth in the 2024. This episode is packed with insights from two distinguished speakers: Erica Sosnowski: Managing Partner at Sosna and Co, a leading business development firm in the life sciences industry, with a stellar track record of closing over $250 million in deals. Jennifer Andrews: CEO of Freshly Marketing, a seasoned...
info_outline
Dialogue with African Biotech Leaders: Navigating Funding and Investment
Africa Biotech Conversations
Welcome to another insightful episode of the Dialogue with African Biotech Leaders. In this episode, we focus on a critical aspect of biotechnology entrepreneurship—funding and investment. This episode was recorded as a live plenary session at BIO Africa 2023 in Durban, South Africa, and features in-depth discussions on funding challenges and opportunities in the African biotech landscape. Join our distinguished panelists: Dr. Allama Elmehdi: CEO of Prophamedis International from Mauritania, sharing insights on the funding landscape in West Africa, particularly Francophone Africa, and the...
info_outlineWelcome to another special episode of the Dialogue with African Biotech Leaders series, dedicated to exploring the theme of biotechnology for gender equality.
In this episode, we delve into the intersection of biotechnology and gender equality, discussing both the challenges and successes within this dynamic field. Our goal is to envision a future where biotechnology serves as a catalyst for positive change.
Join us as we introduce our distinguished panelists:
- Dr. Sibongile Gumbi: Founder and CEO of Smart Biotech, South Africa, with a PhD in pharmacology, and numerous certifications in finance, intellectual property, and technology management.
- Dr. Sarah Carroll: Co-founder and CEO of Mari Health Solutions, South Africa, leveraging proteomics and bioinformatics to optimize aquaculture practices.
- Dr. Allama El Mehdi: CEO of Prophamedis International from Mauritania, a medical doctor with an MBA specializing in biotechnology and international business administration.
- Dr. Shameem Fawdar: Deputy CEO of Axonova Pharma Limited, Mauritius, with a PhD in stem cell and cancer biology.
Throughout this episode, we explore:
- The remarkable achievements of these trailblazing women in the biotech industry.
- Personal stories and experiences of overcoming challenges in a traditionally male-dominated field.
- The role of mentorship and the importance of building networks for young women in biotech.
- How biotech innovations are addressing gender-specific health issues and empowering women economically.
- Insights on how men can support gender equality in the biotech sector.
We also discuss the broader implications of gender equality in biotech, emphasizing the need for fair attitudes, open minds, and inclusive practices to drive innovation and societal growth.
Stay Connected: Join the Dialogue with African Biotech Leaders LinkedIn page for updates on future episodes and events: https://www.linkedin.com/groups/9389009/
Watch the video recording of this episode on YouTube: https://www.youtube.com/watch?v=vID0EN7IBE8